8-K: American Healthcare REIT Posts Strong Q4, Full Year 2025 Results

American Healthcare REIT reports significant growth in net income and Same-Store NOI for Q4 and full year 2025, alongside positive 2026 guidance.

Summary

• GAAP net income attributable to controlling interest was $10.8 million ($0.06 per diluted share) for Q4 2025 and $69.8 million ($0.42 per diluted share) for the full year 2025.
• Normalized Funds from Operations (NFFO) attributable to common stockholders reached $0.46 per diluted share for Q4 2025 and $1.72 per diluted share for the full year 2025.
• Total portfolio Same-Store Net Operating Income (NOI) grew by 11.8% in Q4 2025 and 14.2% for the full year 2025, marking the second consecutive year of double-digit growth.
• Senior Housing Operating Properties (SHOP) and Integrated Senior Health Campuses (ISHC) segments led NOI growth, with SHOP achieving 24.6% in Q4 2025 and 25.2% for the full year 2025.
• Over $950 million was invested in new acquisitions within the ISHC and SHOP segments during 2025.
• The company reduced its Net Debt-to-Annualized Adjusted EBITDA ratio from 3.5x as of September 30, 2025, to 3.4x as of December 31, 2025.
• Issued full year 2026 guidance projecting total portfolio Same-Store NOI growth of 7.0% to 11.0% and NFFO per diluted share of $1.99 to $2.05.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this filing positively due to strong financial performance, including a significant turnaround to net income profitability, robust Same-Store NOI growth, improved leverage, and optimistic 2026 guidance, despite some minor concerns regarding tenant coverage ratios and potential delays in pipeline deals.

Positives

• GAAP net income attributable to controlling interest significantly improved from a loss of $(31.8) million in Q4 2024 to a profit of $10.8 million in Q4 2025, and from a loss of $(37.8) million in FY 2024 to a profit of $69.8 million in FY 2025.
• Normalized FFO per diluted share increased by 15.0% to $0.46 in Q4 2025 and by 22.0% to $1.72 for FY 2025 compared to the prior year.
• Achieved double-digit total portfolio Same-Store NOI growth for the second consecutive year, with 14.2% for FY 2025.
• SHOP segment demonstrated exceptional Same-Store NOI growth of 24.6% in Q4 2025 and 25.2% for FY 2025.
• Net Debt-to-Annualized Adjusted EBITDA improved by 0.1x to 3.4x, indicating stronger balance sheet management.
• Successfully raised significant capital through ATM programs and a forward follow-on common equity offering, totaling approximately $1.116 billion in gross proceeds (settled and new forward agreements).
• Interest expense, net, decreased from $(127.7) million in FY 2024 to $(85.8) million in FY 2025.

Negatives

• Impairment of real estate investments increased slightly from $(45.8) million in FY 2024 to $(49.9) million in FY 2025.
• Some Triple-Net Leased Properties show tenant EBITDAR coverage ratios below 1.0x, specifically 1.6% of Cash NOI with <0.80x coverage and 0.6% with 0.90x-0.99x coverage, indicating potential tenant financial stress for a small portion of the portfolio.

Risks

• Changing macroeconomic conditions could impact financial performance.
• Domestic legal and fiscal policies may affect operations and profitability.
• Geopolitical conditions could introduce unforeseen challenges.
• Actual results may differ materially from forward-looking statements due to various factors, including those disclosed in the company's Annual Report on Form 10-K for the year ended December 31, 2024.

Future Outlook

The company is issuing full year 2026 guidance, anticipating total portfolio Same-Store NOI growth of 7.0% to 11.0% and NFFO per diluted share guidance of $1.99 to $2.05. This guidance does not include any additional transaction or capital markets activity beyond what has already been disclosed as completed. The company expects continued Same-Store NOI growth, particularly led by its SHOP segment, and another year of double-digit NFFO per share increases, driven by disciplined revenue management, increased occupancy, strong rate growth, and effective expense control.

Management Comments

• Gabe Willhite, Chief Operating Officer: "2025 marked our second consecutive year with double-digit total portfolio Same-Store NOI growth as we continue to benefit from the unprecedented demand-and-supply fundamentals in the long-term care industry."
• Gabe Willhite, Chief Operating Officer: "As we enter the new year, we remain focused and steadfast on establishing best-in-class revenue management practices across our operating portfolio, leveraging the platform we continue to invest in with Trilogy Management Services."
• Gabe Willhite, Chief Operating Officer: "Additionally, at these higher levels of occupancies, we continue to benefit from operating leverage from each new move-in, which should help us achieve another year of double-digit Same-Store NOI growth within our ISHC and SHOP segments."
• Brian Peay, Chief Financial Officer: "We achieved over 20% NFFO per share growth in 2025 compared to the prior year, marking a record year for AHR."
• Brian Peay, Chief Financial Officer: "Looking ahead at 2026, we anticipate continued Same-Store NOI growth throughout our portfolio, which we expect will enable us to deliver another year of double-digit NFFO per share increases."
• Brian Peay, Chief Financial Officer: "We expect this growth to be led, once again, by our SHOP segment, which has been our fastest growing segment over the last two years and now is the second largest segment of our portfolio."
• Brian Peay, Chief Financial Officer: "We continue to source attractive equity capital under our ATM Program, which, in combination with our opportunistic follow-on common equity offering completed in November 2025, has allowed us to fully match fund all of our recent acquisitions and our in-process development pipeline."

Industry Context

StockSavvy.ai notes that American Healthcare REIT's strong performance, particularly in its senior housing operating properties (SHOP) and integrated senior health campuses (ISHC) segments, aligns with broader industry trends benefiting from increasing demand and supply fundamentals in the long-term care sector. The focus on revenue management and operating leverage suggests a strategic approach to capitalize on demographic shifts and post-pandemic recovery in healthcare real estate.

Comparison to Industry Standards

• The filing does not provide specific comparisons to other publicly traded REITs or industry benchmarks beyond its own historical performance and internal targets. Therefore, a direct assessment against global benchmarks or specific comparable companies is not possible based solely on the provided information.

Stakeholder Impact

• Shareholders: Positive impact due to strong financial performance, increased NFFO per share, improved balance sheet, and continued cash distributions.
• Employees/Residents: The company's mission to provide and facilitate high-quality care and health outcomes for residents, supported by investments in operating partners and revenue management practices, suggests a positive impact on care quality and operational stability.
• Creditors: Improved Net Debt-to-Annualized Adjusted EBITDA ratio and significant capital raises enhance the company's ability to service its debt, positively impacting creditors.

Next Steps

• Host a webcast and conference call on February 27, 2026, at 1:00 p.m. Eastern Time to discuss Q4 2025 results and recent events.
• Continue to focus on establishing best-in-class revenue management practices across the operating portfolio, leveraging the Trilogy Management Services platform.
• Work towards closing over $230 million of awarded deals in the investment pipeline by the end of 2026, though timing is not guaranteed.
• Fund approximately $100 million to $120 million for new development starts and ongoing development projects in 2026.

Key Dates

Recommendation

The company demonstrated a strong financial turnaround in 2025, moving from a net loss to significant profitability, coupled with impressive double-digit Same-Store NOI growth across its core segments. The improved leverage ratio and proactive capital raising to fund acquisitions and development indicate sound financial management and strategic growth. The positive 2026 guidance, anticipating continued NFFO and NOI growth, suggests a favorable outlook for investors seeking exposure to the resilient healthcare real estate sector.

Keywords

Healthcare REIT, Senior Housing, Skilled Nursing, Outpatient Medical, Real Estate Investment Trust, NOI Growth, NFFO, Earnings Release, Q4 2025 Results, Full Year 2025 Results, 2026 Guidance, Equity Offering, Debt Management, AHR